Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 78.30B | 75.93B | 74.88B | 71.98B | 62.27B | 55.25B |
Gross Profit | 30.22B | 29.82B | 29.12B | 25.85B | 22.74B | 19.89B |
EBITDA | 15.90B | 15.34B | 15.11B | 13.48B | 11.64B | 9.92B |
Net Income | 9.90B | 8.30B | 7.95B | 3.72B | 5.26B | 4.04B |
Balance Sheet | ||||||
Total Assets | 162.46B | 147.81B | 145.07B | 151.50B | 139.61B | 123.90B |
Cash, Cash Equivalents and Short-Term Investments | 26.01B | 10.22B | 11.13B | 11.70B | 10.68B | 15.30B |
Total Debt | 56.69B | 47.92B | 46.60B | 50.64B | 48.70B | 44.57B |
Total Liabilities | 96.42B | 91.58B | 92.01B | 96.70B | 90.33B | 84.07B |
Stockholders Equity | 60.59B | 51.26B | 47.79B | 48.90B | 44.37B | 36.39B |
Cash Flow | ||||||
Free Cash Flow | 10.53B | 9.58B | 10.09B | 8.16B | 8.27B | 6.53B |
Operating Cash Flow | 12.82B | 11.66B | 12.24B | 10.24B | 10.00B | 8.03B |
Investing Cash Flow | -6.77B | -3.28B | -3.18B | -2.49B | -15.49B | -5.18B |
Financing Cash Flow | 1.19B | -8.88B | -8.73B | -7.50B | 785.00M | 4.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €185.54B | 18.80 | 14.27% | 2.20% | 0.55% | 22.60% | |
64 Neutral | $10.92B | 16.41 | 8.85% | 2.02% | 2.59% | -16.33% | |
― | €1.58B | 14.47 | -6.59% | ― | ― | ― | |
― | €10.46B | 26.82 | 17.92% | ― | ― | ― | |
― | €3.23B | 11.27 | 11.92% | ― | ― | ― | |
― | €4.18B | 14.51 | 15.37% | ― | ― | ― | |
― | $86.04B | 86.11 | 9.35% | ― | ― | ― |